Protocol No.: V212-011; "A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy"

  • Markowitz, Avi (PI)

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date6/13/11 → 12/31/16

    Funding

    • Merck Sharp and Cohme Corporation: $91,750.00